Presented by
Dunhill Ventures
Hosted By
Private Business Breakfast featuring Mitochon Pharmaceuticals
Registration
Approval Required
Your registration is subject to approval by the host.
About Event
Join us for a Investor Breakfast with Mitochon Pharma Advancing Breakthrough Treatments for Neurodegenerative Diseases
We are delighted to invite you to an exclusive Family Offices and Private Investors Brunch in London, where we spotlight a pioneering biotech company making significant strides in the fight against neurodegenerative diseases—Mitochon Pharma.
📍 London
📅Thursday, 19 June 2025
🕘9:00AM to 12:30PM
About Mitochon Pharma
Mitochon Pharma is a clinical-stage biopharmaceutical company revolutionizing how we treat conditions such as ALS, Huntington’s, Parkinson’s, MS, and Traumatic Brain Injury. Their focus? Oral, once-daily compounds that enhance mitochondrial function and reduce oxidative stress—a core driver of neurodegeneration.
Presented by
Dunhill Ventures
Hosted By